University of Oklahoma researchers collaborate with Xironetic, using augmented reality for neurosurgical procedures to improve patient safety and training.

Scientists from the University of Oklahoma discovered that the hormone FGF21 may reverse fatty liver disease by signaling the brain to initiate liver repair, a finding that may lead to new treatments.

Chen Wang from the University of Oklahoma receives a fellowship for kidney cancer diagnostic research, aiming to improve biopsy accuracy with an OCT probe.